{
  "id": 2012478,
  "title": "Aurinia Settles Patent Litigation with Teva",
  "url": "https://urgent.news/2026/08/19/aurinia-settles-patent-litigation-with-teva",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-19T20:10:02.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/aurinia-settles-patent-litigation-with-teva"
  },
  "original_language": "en",
  "account": null,
  "summary": "EDMONTON, Alberta — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced that it and its subsidiary, Aurinia Pharma U.S., Inc., (collectively, “Aurinia”) have entered into a settlement agreement with Teva Pharmaceuticals Inc. (“Teva”) to resolve patent infringement litigation relating to Teva’s filing of an Abbreviated New Drug Application seeking to market its generic 7.9 mg voclosporin…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}